Flotation
Exits: May 26, 2022
A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.
Exits: May 24, 2022
A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.
Microba makes tracks to ASX
The gut microbiome drug developer went public in a $22.5m offering priced at the foot of its range.
Exits: February 7, 2022
A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.
Exits: February 1, 2022
A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.
SenseTime scores $851m in initial public offering
The producer of image recognition technology stemmed from Chinese University of Hong Kong’s Media Lab has gone public in Hong Kong as the Chinese government introduces new regulations governing foreign IPOs.
Exits: November 26, 2021
A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.
Blade to get a slice of Nasdaq action
Johns Hopkins spinout Blade Therapeutics has agreed to a reverse merger that will net it $24.3m in Pipe financing from backers including Osage University Partners.
Other News
Entrada Therapeutics enters Nasdaq
The Ohio State spinout has gone public in an upsized IPO sized at approximately $182m.
Pyxis progresses to stock market
Having priced its shares at the top of its range, UChicago spinout Pyxis Oncology suffered a drop on the first day of trading.
Exscientia expands IPO to over $350m
The cancer drug developer has closed its initial public offering after underwriters exercised the greenshoe option.
Pyxis picks price range
UChicago spinout Pyxis Oncology is aiming to raise more than $153m in its initial public offering, having set a price range of $14 to $16.
Exscientia establishes Nasdaq listing
The Dundee spinout has raised more than $304m in its IPO in the US, with another $160m secured through a concurrent private placement.
Editor's Picks
The Big Deal: Acrivon gives the IPO market a boost
The cancer drug developer popped after an upsized offering, allowing Alexandria Venture Investments to exit and showing the IPO market is still breathing in the US.
The Standout Six: The deals you need to know about this week
Healthcare companies may be driving a public markets recovery while Lunar Energy, helmed by Tesla's former head of energy, has emerged from stealth with $300m.
GoTo gets $1.1bn in initial public offering
The multicorporate-backed diversified mobile app operator has listed on IDX having priced its shares at near the top of their range.
Braze breaches public markets in $520m IPO
Citi Ventures-backed Braze priced the offering above its range and it valued the customer engagement software producer at almost $5.9bn.